The New Era of Glaucoma Micro-stent Surgery

Ophthalmology and Therapy

Volumn 5, Issue 2, 2016, Pages 135-146

  Manasses, Demetrios T ^a   Au, Leon ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

Glaucoma; Micro stents; Minimally invasive glaucoma surgery

Indexed keywords

GLAUCOMA; GLAUCOMA SURGERY; HUMAN; IMPLANTATION; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MICRO STENT; MINIMALLY INVASIVE GLAUCOMA SURGERY; MULTICENTER STUDY (TOPIC); OPEN ANGLE GLAUCOMA; OPHTHALMOLOGICAL IMPLANT; OPTICAL COHERENCE TOMOGRAPHY; PHACOEMULSIFICATION; PHASE 4 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHLEMM CANAL; TRABECULAR MESHWORK; TREATMENT OUTCOME;

EID: 85018360169     PISSN: 21938245     EISSN: 21936528     Source Type: Journal    
DOI: 10.1007/s40123-016-0054-6     Document Type: Review

References (35)

1. Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE, US iStent Study Group. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118(3):459–67.
2. Craven ER, Katz LJ, Wells JM, Giamporcaro JE, iStent Study Group. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38(8):1339–45.
3. Fea AM. Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma: randomized double-masked clinical trial. J Cataract Refract Surg. 2010;36(3):407–12.
4. Fea AM, Consolandi G, Zola M, et al. Micro-bypass implantation for primary open-angle glaucoma combined with phacoemulsification: 4-year follow-up. J Ophthalmol. 2015;2015:795357.
5. Arriola-Villalobos P, Martínez-de-la-Casa JM, Díaz-Valle D, et al. Mid-term evaluation of the new Glaukos iStent with phacoemulsification in coexistent open-angle glaucoma or ocular hypertension and cataract. Br J Ophthalmol. 2013;97(10):1250–5.
6. Neuhann TH. Trabecular micro-bypass stent implantation during small-incision cataract surgery for open-angle glaucoma or ocular hypertension: long-term results. J Cataract Refract Surg. 2015;41(12):2664–71.
7. Hann CR, Vercnocke AJ, Bentley MD, Jorgensen SM, Fautsch MP. Anatomic changes in Schlemm’s canal and collector channels in normal and primary open-angle glaucoma eyes using low and high perfusion pressures. Investig Opthalmol Vis Sci. 2014;55(9):5834.
8. Bahler CK, Smedley GT, Zhou J, Johnson DH. Trabecular bypass stents decrease intraocular pressure in cultured human anterior segments. Am J Ophthalmol. 2004;138(6):988–94.
9. Belovay GW, Naqi A, Chan BJ, Rateb M, Ahmed IIK. Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma. J Cataract Refract Surg. 2012;38(11):1911–7.
10. Katz LJ, Erb C, Carceller GA, et al. Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication. Clin Ophthalmol Auckl NZ. 2015;9:2313–20.
11. Bahler CK, Hann CR, Fjield T, Haffner D, Heitzmann H, Fautsch MP. Second-generation trabecular meshwork bypass stent (iStent inject) increases outflow facility in cultured human anterior segments. Am J Ophthalmol. 2012;153(6):1206–13.
12. ®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clin Ophthalmol Auckl NZ. 2014;8:875–82.
13. ® inject system for open-angle glaucoma: synergy trial. Adv Ther. 2014;31(2):189–201.
14. Hays CL, Gulati V, Fan S, Samuelson TW, Ahmed IIK, Toris CB. Improvement in outflow facility by two novel microinvasive glaucoma surgery implants. Invest Ophthalmol Vis Sci. 2014;55(3):1893–900.
15. Camras LJ, Yuan F, Fan S, et al. A novel Schlemm’s Canal scaffold increases outflow facility in a human anterior segment perfusion model. Invest Ophthalmol Vis Sci. 2012;53(10):6115–21.
16. Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-Casa JM, et al. A randomized trial of a Schlemm’s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology. 2015;122(7):1283–93.
17. Compare the Hydrus Microstent (TM) to the iStent for lowering IOP in glaucoma patients having cataract surgery (Hydrus III). https://clinicaltrials.gov/ct2/show/NCT02024464 [Internet].
18. Comparing effectiveness of the hydrus microstent (TM) to two iStents to lower IOP in Phakic eyes (Hydrus V). https://clinicaltrials.gov/ct2/show/NCT02023242 [Internet].
19. Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002;47(Suppl 1):S53–64.
20. Emi K, Pederson JE, Toris CB. Hydrostatic pressure of the suprachoroidal space. Invest Ophthalmol Vis Sci. 1989;30(2):233–8.
21. Razeghinejad MR, Spaeth GL. A history of the surgical management of glaucoma. Optom Vis Sci. 2011;88(1):E39–47.
22. Hoeh H, Ahmed IIK, Grisanti S, et al. Early postoperative safety and surgical outcomes after implantation of a suprachoroidal micro-stent for the treatment of open-angle glaucoma concomitant with cataract surgery. J Cataract Refract Surg. 2013;39(3):431–7.
23. Höh H, Grisanti S, Grisanti S, Rau M, Ianchulev S. Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monatsblätter Für Augenheilkd. 2014;231(4):377–81.
24. Grisanti S, Margolina E, Hoeh H, et al. Supraciliary microstent for open-angle glaucoma: clinical results of a prospective multicenter study. Ophthalmol Z Dtsch Ophthalmol Ges. 2014;111(6):548–52.
25. García-Feijoo J, Rau M, Grisanti S, et al. Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a Multicenter Study. Am J Ophthalmol. 2015;159(6):1075–1081.e1.
26. Yu D-Y, Morgan WH, Sun X, et al. The critical role of the conjunctiva in glaucoma filtration surgery. Prog Retin Eye Res. 2009;28(5):303–28.
27. Lewis RA. Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cataract Refract Surg. 2014;40(8):1301–6.
28. Sheybani A, Reitsamer H, Ahmed IIK. Fluid dynamics of a novel micro-fistula implant for the surgical treatment of glaucoma. Invest Ophthalmol Vis Sci. 2015;56(8):4789–95.
29. Sheybani A, Lenzhofer M, Hohensinn M, Reitsamer H, Ahmed IIK. Phacoemulsification combined with a new ab interno gel stent to treat open-angle glaucoma: pilot study. J Cataract Refract Surg. 2015;41(9):1905–9.
30. Sheybani A, Dick B, Ahmed IIK. Early clinical results of a novel ab interno gel stent for the surgical treatment of open-angle glaucoma. J Glaucoma. 2015. doi:10.1097/IJG.0000000000000352
31. Sheybani A, Ahmed IK. Ab interno gelatin stent with mitomycin-C combined with cataract surgery for treatment of open-angle glaucoma: 1-year results. In: Presented at ASCRS 2015.
32. Pinchuk L, Wilson GJ, Barry JJ, Schoephoerster RT, Parel J-M, Kennedy JP. Medical applications of poly(styrene-block-isobutylene-block-styrene) (“SIBS”). Biomaterials. 2008;29(4):448–60.
33. Batlle JF, Fantes F, Riss I, et al. Three-year follow-up of a novel aqueous humor microshunt. J Glaucoma. 2016;25(2):e58–65.
34. Nagar M, Ogunyomade A, O’Brart DPS, Howes F, Marshall J. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol. 2005;89(11):1413–7.
35. Iordanous Y, Kent JS, Hutnik CML, Malvankar-Mehta MS. Projected cost comparison of trabectome, iStent, and endoscopic cyclophotocoagulation versus glaucoma medication in the Ontario Health Insurance Plan. J Glaucoma. 2014;23(2):e112–8.